IDO1 Mouse Monoclonal Antibody [Clone ID: UMAB126]
CAT#: UM500091
IDO1 mouse monoclonal antibody,clone UMAB126
Size: 30 ul
Formulation: Carrier-Free
View other "UMAB126" antibodies (2)
Need it in bulk or conjugated?
Get a free quote
CNY 2,999.00
Cited in 11 publications. |
CNY 300.00
CNY 1,430.00
CNY 2,900.00
CNY 6,650.00
Specifications
Product Data | |
Clone Name | UMAB126 |
Applications | 10k-ChIP, IF, IHC, WB |
Recommend Dilution | IHC 1:100~200 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Full length human recombinant protein of human IDO1(NP_002155) produced in HEK293T cell. |
Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 0.5~1.0 mg/ml (Lot Dependent) |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 45.1 kDa |
Gene Name | indoleamine 2,3-dioxygenase 1 |
Database Link | |
Background | This gene encodes indoleamine 2,3-dioxygenase (IDO) - a heme enzyme that catalyzes the first and rate-limiting step in tryptophan catabolism to N-formyl-kynurenine. This enzyme acts on multiple tryptophan substrates including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin. This enzyme is thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation, and antioxidant activity. Through its expression in dendritic cells, monocytes, and macrophages this enzyme modulates T-cell behavior by its peri-cellular catabolization of the essential amino acid tryptophan. [provided by RefSeq, Feb 2011] |
Synonyms | IDO; IDO-1; INDO |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Metabolic pathways, Tryptophan metabolism |
Citations (11)
The use of this Antibodies has been cited in the following citations: |
---|
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
,Smalley, I;Chen, Z;Phadke, M;Li, J;Yu, X;Wyatt, C;Evernden, B;Messina, JL;Sarnaik, A;Sondak, VK;Zhang, C;Law, V;Tran, N;Etame, A;Macaulay, RJB;Eroglu, Z;Forsyth, PA;Rodriguez, PC;Chen, YA;Smalley, KSM;,
Clinical cancer research : an official journal of the American Association for Cancer Research
,PubMed ID 34035069
[IDO1]
|
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
,Heng, B;Bilgin, A;Lovejoy, D;Tan, V;Milioli, H;Gluch, L;Bustamante, S;Sabaretnam, T;Moscato, P;Lim, C;Guillemin, G;,
Breast Cancer Res
,PubMed ID 33109232
[IDO1]
|
Differential kynurenine pathway metabolism in highly-metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
,Heng, B;Bilgin, A;Lovejoy, D;Tan, V;Milioli, H;Gluch, L;Moscato, P;Lim, C;Guillemin, G;,
Research Square
[IDO1]
|
Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype
,Takada, K;Toyokawa, G;Kinoshita, F;Jogo, T;Kohashi, K;Wakasu, S;Ono, Y;Tanaka, K;Oba, T;Osoegawa, A;Tagawa, T;Azuma, K;Okamoto, I;Shimokawa, M;Oda, Y;Mori, M;,
J. Cancer Res. Clin. Oncol.
,PubMed ID 32405745
[IDO1]
|
PD-L1/IDO1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features
,Kiyozawa, D;Takamatsu, D;Kohashi, K;Kinoshita, F;Ishihara, S;Toda, Y;Eto, M;Oda, Y;,
Hum. Pathol.
,PubMed ID 32360490
[IDO1]
|
Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma
,Takada, K;Shimokawa, M;Tanaka, K;Kohashi, K;Haro, A;Osoegawa, A;Tagawa, T;Azuma, K;Okamoto, I;Oda, Y;Mori, M;,
PLoS ONE
,PubMed ID 31163080
[IDO1]
|
Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy
,Takada, K;Kohashi, K;Shimokawa, M;Haro, A;Osoegawa, A;Tagawa, T;Seto, T;Oda, Y;Maehara, Y;,
Lung Cancer
,PubMed ID 30642449
[IDO1]
|
Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with MCPyV status and prognosis in Merkel cell carcinoma
,Wardhani, LO;Matsushita, M;Iwasaki, T;Kuwamoto, S;Nonaka, D;Nagata, K;Kato, M;Kitamura, Y;Hayashi, K;,
Hum. Pathol.
,PubMed ID 30240768
[IDO1]
|
Radiological Features of IDO1+/PDL1+ Lung Adenocarcinoma: A Retrospective Single-institution Study
,Takada, K;Toyokawa, G;Tagawa, T;Shimokawa, M;Kohashi, K;Haro, A;Osoegawa, A;Oda, Y;Maehara, Y;,
Anticancer Res.
,PubMed ID 30194181
[IDO1]
|
Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma
,Kozuma, Y;Takada, K;Toyokawa, G;Kohashi, K;Shimokawa, M;Hirai, F;Tagawa, T;Okamoto, T;Oda, Y;Maehara, Y;,
Eur. J. Cancer
,PubMed ID 30014971
[IDO1]
|
Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers
,Puccetti, P;Fallarino, F;Italiano, A;Soubeyran, I;MacGrogan, G;Debled, M;Velasco, V;Bodet, D;Eimer, S;Veldhoen, M;Prendergast, GC;Platten, M;Bessede, A;Guillemin, GJ;,
PLoS ONE
,PubMed ID 25881064
[IDO1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
UM500091CF | Carrier-free (BSA/glycerol-free) IDO1 mouse monoclonal antibody,clone UMAB126 |
CNY 4,999.00 |
|
UM570091 | IDO1 mouse monoclonal antibody,clone UMAB126 |
CNY 1,150.00 |